×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
Head-to-head study of oxelumab and adalimumab in a mousethrough OX40 breaks peripheral T cell tolerance (Bansal-Pakala et al., 2001). Therefore, agonistic antibodies of OX40 are in
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form